Cargando…
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
IMPORTANCE: Active surveillance (AS) is endorsed by clinical guidelines as the preferred management strategy for low-risk prostate cancer, but its use in contemporary clinical practice remains incompletely defined. OBJECTIVE: To characterize trends over time and practice- and practitioner-level vari...
Autores principales: | Cooperberg, Matthew R., Meeks, William, Fang, Raymond, Gaylis, Franklin D., Catalona, William J., Makarov, Danil V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982696/ https://www.ncbi.nlm.nih.gov/pubmed/36862409 http://dx.doi.org/10.1001/jamanetworkopen.2023.1439 |
Ejemplares similares
-
A vision for closing the evidence-practice gap in the management of low-grade prostate cancer
por: Leapman, Michael S, et al.
Publicado: (2023) -
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US
por: Washington, Samuel L., et al.
Publicado: (2020) -
Impact of the COVID-19 Pandemic on Urological Care Delivery in the United States
por: Lee, Daniel J., et al.
Publicado: (2021) -
Trends in Incidence of Metastatic Prostate Cancer in the US
por: Desai, Mihir M., et al.
Publicado: (2022) -
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
por: Shore, Neal D., et al.
Publicado: (2022)